Ocular Behçet s disease presenting with retinal tear and panuveitis
 
Yazarlar (4)
Prof. Dr. Kemal ÖRNEK Kirikkale Üniversitesi, Türkiye
Z. Onaran
Kirikkale Üniversitesi, Türkiye
A. Ergin
Kirikkale Üniversitesi, Türkiye
N. F. Yalçndag
Ankara Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Eye
Dergi ISSN 0950-222X Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 11-2008
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi
Cilt / Sayı / Sayfa 22 / 11 / 1450–1451 DOI 10.1038/eye.2008.56
Makale Linki https://www.nature.com/articles/eye200856.pdf
Özet
I thank the authors for their interesting case series describing the use of ketamine sedation for the treatment of retinopathy of prematurity. 1 I agree that no ideal agent exists but have reservations about the use of ketamine in this age group, which merits discussion. There still remain questions over the potential neurotoxic effects of some anaesthetic agents in this age group, and ketamine has been the most strongly implicated in the debate. 2 Volatile agents, midazolam, and ketamine can cause neuroapoptosis (programmed neuronal cell death) in the neonatal rat model, evidence which has concerned the Food and Drug Administration in the United States to instigate trials in a primate model. 2 Exposure may result in adverse cognitive sequelae, but at present, the risk is difficult to quantify. 2 Remifentanil has been shown to have predictable pharmacokinetics and pharmacodynamics in neonates, importantly an …
Anahtar Kelimeler
Science Direct
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 3
Scopus 1
Web of Science 2
Ocular Behçet s disease presenting with retinal tear and panuveitis

Paylaş